Sangair AB
559080-3317ActiveDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Oversikt
- 3
- Ansatte
- 0 SEK
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Susanne Olausson
Board Member
Johan Sjöholm
Board Member and Founder
Henrik Rundgren
Board member
Martin Wiklund
Board Member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Sangair AB is a Swedish biotechnology company focused on developing innovative solutions for critical medical conditions. Their core innovation is SangAsept, a unique process designed to treat blood extracorporeally, meaning outside the body. This technology immediately targets and reduces harmful b...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Tillverkning av medicinska och dentala instrument och tillbehör
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559080331701
Beslutningstakere
6 kontakter i FunnelfeedrSusanne Olausson
Board Member
Johan Sjöholm
Board Member and Founder
Henrik Rundgren
Board member
Martin Wiklund
Board Member
Niclas Jonasson
Chairman of the Board
Andre kontakter
Sara Weman
Engineer
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrModus Therapeutics Holding AB
1–4 ansatteSwedish biotech developing sevuparin for severe inflammatory conditions.
Modus Therapeutics AB
Swedish biotech developing sevuparin for severe inflammatory diseases.
Gradientech AB
20–49 ansatteDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
bioMérieux Sweden AB
20–49 ansatteWorld leader developing in vitro diagnostics for health and safety.
Aptahem AB
0 ansatteBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Utforsk mer
Spørsmål om Sangair AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo